Hims vs Ro
Two of the biggest names in telehealth go head to head on GLP-1 treatment.
Researched & verified by goglp1.com Editorial Team — Last updated May 2026
Detailed Criteria Scores
Key Differences
- Monthly Price: Hims — $199/mo all-in · Ro — $199/mo starting
- Medications: Hims — Compound Sema + Tirz · Ro — FDA-approved + Compound
- Shipping: Hims — Free 3-5 day · Ro — Free 3-5 day
- Intake: Hims — Async questionnaire · Ro — Async questionnaire
- Insurance: Hims — Not accepted · Ro — Coordination available
- Score: Hims — 8.6/10 · Ro — 9.1/10
- HSA/FSA: Hims — Accepted · Ro — Accepted
- Platform: Hims — Consumer wellness focus · Ro — Full telehealth suite
Brand Heritage and Trust
Hims has been a household name in telehealth since its launch in 2017. Originally focused on men's health (hair loss, erectile dysfunction), the company has expanded into a broader wellness platform including mental health, primary care, and now weight loss. Their brand is consumer-friendly, approachable, and well-recognized — particularly among younger demographics. Hims went public via SPAC in 2021 and trades on NYSE under the ticker HIMS. Ro has taken a different path. Originally launched as Roman (focused on men's health like Hims), Ro rebranded and expanded aggressively into a full-service telehealth platform. They acquired multiple healthcare companies and built what is now the largest telehealth infrastructure in the United States, serving over 6 million patient visits. Ro has invested heavily in clinical infrastructure, including a dedicated pharmacy network and insurance coordination capabilities. [1] Both brands are legitimate and well-established. However, Ro has invested more heavily in clinical infrastructure and insurance partnerships, while Hims has focused on consumer experience and brand marketing. For GLP-1 treatment specifically, Ro's deeper clinical investment gives it an edge.
Medication Access: The Big Differentiator
The single most important difference between Hims and Ro for GLP-1 treatment is medication access. Hims offers only compounded GLP-1 medications — generic semaglutide and tirzepatide produced by licensed compounding pharmacies. They do not offer FDA-approved branded GLP-1s like Wegovy or Zepbound. Ro offers both compound and FDA-approved branded options. This means that if your insurance covers Wegovy or Zepbound, Ro can coordinate with your plan to potentially reduce your cost significantly. For patients with good insurance, this could mean paying far less than the $199/mo cash price for compound alternatives. [2] It is important to understand the regulatory landscape for compounded GLP-1s. The FDA has issued guidance on compounding semaglutide and tirzepatide, noting that these are not FDA-approved products and may differ from branded medications in formulation, purity, and efficacy. Both Hims and Ro source from licensed compounding pharmacies, but patients should be aware that compounded medications are not subject to the same FDA approval process as branded drugs. Having the option to access FDA-approved medications through Ro is a meaningful advantage.
Pricing Structure and Transparency
Hims and Ro both advertise a $199/mo starting price for compound GLP-1 treatment. However, the pricing structures differ in subtle ways. Hims emphasizes their "all-in" pricing — $199/mo covers the provider evaluation, medication, and shipping with no additional fees. This is genuinely straightforward and one of Hims' strongest selling points. Ro's $199/mo is for compound options only. If you choose branded GLP-1s through Ro, the price depends entirely on your insurance coverage. Ro's insurance team will verify your benefits before you commit, so there are no surprises, but the final price can range from a small copay to the full retail cost of branded GLP-1s. [3] For patients paying cash without insurance, Hims and Ro are essentially the same price. For patients with insurance that covers GLP-1s, Ro may be significantly cheaper after insurance coordination. For patients who specifically want compound medications, Hims offers a slightly more streamlined experience focused on that option.
Patient Experience and Support
Hims provides a clean, modern digital experience optimized for consumer convenience. Their mobile app and website are easy to navigate, and the intake process takes under 15 minutes. After enrollment, patients can message their provider through the app and track medication shipments. The overall experience is smooth and well-designed for first-time telehealth users. Ro's platform is more clinically oriented. The app includes medication tracking, refill scheduling, care team messaging, and integration with other Ro health services. Ro has also invested in a dedicated support team for GLP-1 patients, which we found to be responsive and knowledgeable during testing. [4] Both platforms offer adequate support, but Ro's clinical infrastructure is more robust. Hims wins on simplicity and consumer-friendliness. If you want a set-it-and-forget-it experience, Hims is appealing. If you want more clinical depth and the option to escalate to branded medications, Ro is the stronger choice.
Who Should Choose Each Provider
Choose Hims if you want the simplest possible path to compound GLP-1 treatment at a competitive price. The $199/mo all-in pricing, fast intake, and established brand make it an excellent choice for patients who are comfortable with compounded medications and want a no-fuss experience. Choose Ro if you want the option of FDA-approved branded GLP-1s, need insurance coordination, or value a more clinically robust platform. Ro's larger infrastructure and insurance support make it the better choice for patients with complex medical needs or insurance coverage for branded medications. Both providers are legitimate and effective. The choice ultimately comes down to whether you prioritize simplicity (Hims) or clinical depth and medication flexibility (Ro).
Our Pick: Ro wins on medication flexibility and clinical depth
Hims Strengths & Trade-offs
Strengths
- $199/mo all-in pricing — no surprises
- Established telehealth brand since 2017
- HSA/FSA eligible expenses
- Simple intake process (under 15 minutes)
Trade-offs
- No FDA-approved branded GLP-1s
- Limited tirzepatide availability
- Async-only intake model
Ro Strengths & Trade-offs
Strengths
- FDA-approved Wegovy and Zepbound available
- Largest telehealth platform in the US
- Insurance coordination for branded GLP-1s
- In-app messaging with care team
Trade-offs
- Compound options limited compared to competitors
- Branded GLP-1 pricing varies by insurance
- Async intake (no required video visit)
The Bottom Line
Hims and Ro are closely matched on price, but Ro pulls ahead with FDA-approved medication access, insurance coordination, and a more clinically robust platform. Hims offers a simpler, more consumer-friendly experience for compound-only treatment. If you have insurance that covers GLP-1s or want the option of branded medications, choose Ro. If you want the most straightforward path to compound GLP-1s, choose Hims.